Japan Go IPO Summit
Accessing the U.S. capital markets
June 5th, 2025
Grand Hyatt Hotel, Tokyo, Japan
Palm Ballroom
Co-hosted by MarcumAsia and NASDAQ
The Japan Go IPO Summit is designed for the senior management teams and board members of innovative Japanese companies seeking to raise growth capital and build global brands, as well as venture capital and private equity firms evaluating the optimal exits for their portfolio companies. At this one-day event, you will hear from the most active investment banks and experienced advisors about what is required for a successful IPO and how to maximize the value of your public status once listed.
The pipeline of companies from Japan that are preparing to list in the U.S. markets is growing rapidly. However, a successful IPO requires much more than ringing the opening bell in New York.
Learn the secrets from advisors who have collectively helped hundreds of companies choose the right path for growth and liquidity.
Who Should Attend?
Speakers will share valuable data and lessons learned with an elite audience, including:
Senior management and directors of Japanese private companies,
Venture capital and private equity firms that may have portfolio companies suitable for U.S. listings,
Executives from large Japanese corporates who are considering a carve-out IPO transaction to enhance value creation and innovation.
Space is limited, so sign up today!
What Can You Expect to Learn?
The Japan Go IPO Summit provides a comprehensive overview of everything the audience needs to know about going public in the U.S., including:
What stage of companies and sectors are suitable to list in the U.S.?
What are the advantages and challenges of a U.S. listing compared to a domestic listing on TSE?
How should you prepare to attract a high-quality investment banker?
How can you select and deal with key professionals, including legal counsel and auditors?
What are the advantages and disadvantages of a SPAC merger versus a traditional IPO?
What strategies are available after the IPO to raise additional growth capital, including shelf offerings, ATMs, and PIPEs?
How do public companies use their equity for M&A?
How can you develop institutional sponsorship and liquidity through IR, research coverage, and non-deal roadshows?
